Publication: Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia
| dc.contributor.author | Moral Escudero, Encarnación | |
| dc.contributor.author | Hernández Torres, Alicia | |
| dc.contributor.author | Roura Piloto, Aychel Elena | |
| dc.contributor.author | Albendín Iglesias, Helena | |
| dc.contributor.author | Peláez Ballesta, Ana | |
| dc.contributor.author | García Vázquez, Elisa | |
| dc.contributor.department | Medicina | |
| dc.date.accessioned | 2025-01-31T19:43:31Z | |
| dc.date.available | 2025-01-31T19:43:31Z | |
| dc.description | © The Author 2021 This document is the published version of a published work that appeared in final form in Revista Española de Quimioterapia. This document is made available under the CC-BY-NC 4.0 license http://creativecommons.org/licenses/by-nc/4.0 . To access the final edited and published work see: https://doi.org/10.37201/req/151.2020 | |
| dc.description.abstract | Introducción. Actualmente la prevalencia de coinfección por neumococo en pacientes con SARS-CoV-2 es desconocida. En este trabajo presentamos sus características clínicas, evolución y tratamiento. Material y métodos. Recogida de datos retrospectivos desde agosto a octubre de 2020 en dos hospitales de la región de Murcia. Resultados. Dieciocho pacientes presentaron COVID-19 diagnosticada por PCR e infección por neumococo confirmada con antigenuria, lo que supuso una prevalencia del 2%. El 88% presentaban alteraciones radiológicas a su ingreso (dos pacientes presentaron una radiografía dentro de la normalidad) y un 29% procalcitonina elevada. La mortalidad de nuestra serie fue del 12%. Conclusiones. Podría ser razonable considerar el inicio de terapia antimicrobiana en aquellos casos en los que se tenga una moderada o alta sospecha de coinfección bacteriana, siendo fundamental la retirada del tratamiento antibiótico de forma precoz si ésta no se confirma. | |
| dc.description.abstract | Introduction. Currently the prevalence of pneumococcal coinfection in patients with COVID-19 is unknown. In this work we present its clinical characteristics, evolution and treatment. Material and methods. Retrospective data collection from August to October 2020 in two hospitals in the Murcia region. Results. Eighteen patients had COVID-19 diagnosed by PCR and pneumococcal infection confirmed by antigenuria, which represented a prevalence of 2%. A total of 88% had radiological alterations upon admission (two patients had an X-ray within normality) and 29% had elevated procalcitonin. Mortality in our series was 12%. Conclusions. It could be reasonable to consider the start of antimicrobial therapy in those cases in which there is a moderate or high suspicion of bacterial coinfection, being essential the early suspension of antibiotic treatment if it is not confirmed. | |
| dc.format | application/pdf | es |
| dc.format.extent | 5 | |
| dc.identifier.citation | Rev Esp Quimioter 2021 34(5):491-495 | |
| dc.identifier.doi | https://doi.org/10.37201/req/151.2020 | |
| dc.identifier.issn | Print.: 0214-3429 | |
| dc.identifier.issn | Electronic.: 1988-9518 | |
| dc.identifier.uri | http://hdl.handle.net/10201/149909 | |
| dc.language | spa | es |
| dc.publisher | Sociedad Española de Quimioterapia | |
| dc.relation | Sin financiación externa a la Universidad | es |
| dc.relation.publisherversion | https://seq.es/abstract/rev-esp-quimioter-2021-july-16-2/ | |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Atribución-NoComercial 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.subject | Streptococcus pneumoniae | |
| dc.subject | Neumonía | |
| dc.subject | SARS-CoV2 | |
| dc.subject | Pneumonia | |
| dc.title | Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc/4.0/